Genovese Burford & Brothers Wealth & Retirement Plan Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-26
Closed -$1K 268
2017
Q3
$1K Hold
26
﹤0.01% 389
2017
Q2
$1K Hold
26
﹤0.01% 373
2017
Q1
$1K Sell
26
-24
-48% -$935 ﹤0.01% 402
2016
Q4
$2K Hold
50
﹤0.01% 438
2016
Q3
$1K Sell
50
-12
-19% -$420 ﹤0.01% 406
2016
Q2
$2K Buy
62
+24
+63% +$735 ﹤0.01% 360
2016
Q1
$1K Hold
38
﹤0.01% 364
2015
Q4
$1K Buy
+38
New +$1.18K ﹤0.01% 358

Other funds holding AVNS

Genovese Burford & Brothers Wealth & Retirement Plan Management's AVNS Position: Q4 2017 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Avanos Medical (AVNS) in Q4 2017, closing a stake of 26 shares — an estimated $1K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in AVNS in Q4 2015 and held it in 8 quarters. The position peaked at $2K in Q4 2016. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Avanos Medical position as of Q4 2017 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 26 Avanos Medical shares in Q4 2017, an estimated $1K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Avanos Medical in Q4 2015 and held it in 8 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Avanos Medical position peaked at $2K in Q4 2016.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q4 2017, filed 14 Feb 2018.